Clinical Trial Update: Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer. [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study of the TPF chemotherapy regimen as first-line treatment for metastatic esophageal cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Hokkaido Gastrointestinal Cancer Study Group | Conditions: Esophageal Cancer | Phase 1, Phase 2 | Status: COMPLETED